Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

0.521
Delayed Data
As of Apr 26
 +0.0102 / +2.00%
Today’s Change
0.26
Today|||52-Week Range
1.51
-18.27%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues4.7M5.4M8.5M3.4M
 
 
 
 
 
Cost of Goods Sold494.6K546.5K909.5K242.3K
 
 
 
 
 
Depreciation And Amortization149.6K117.8K111.5K122.5K
 
 
 
 
 
 
Operating ExpensesGross Income4.1M4.7M7.5M3.0M
 
 
 
 
 
General Expenses6.6M5.3M4.1M5.4M
 
 
 
 
 
Research And Development2.7M2.5M1.3M2.4M
 
 
 
 
 
Total Operating Expenses7.3M6.0M5.1M5.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.6M-580.0K3.4M-2.4M
 
 
 
 
 
Extraordinary Credit1.1M1.5M0.001.1M
 
 
 
 
Extraordinary Charge0.000.00-839.3K0.00
 
 
Pre-Tax Equity Earnings-12.2K-2.9K0.000.00
 
 
 
Interest Expense On Debt2.2M7.5M2.6M2.6M
 
 
 
 
 
Other Expenses-37.3K-39.9K-12.5K22.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.7M-6.7M-59.5K-3.9M
 
 
 
 
 
Minority Interest-241.00-116.00-159.00-132.00
 
 
 
 
 
Net Income-3.7M-6.7M-59.4K-3.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS155.3M155.4M155.5M155.5M
 
 
 
 
 
Shares To Calculate EPS Diluted155.3M155.4M155.5M155.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.02-$0.04$0.00-$0.02
 
 
 
 
EPS Diluted-$0.02-$0.04-$0.00-$0.02